Medicago Submits Final Vaccine Data for Canada’s COVID-19 Rolling Review

December 20, 2021
Medicago, a Canadian subsidiary of Mitsubishi Tanabe Pharma, said on December 16 that it has filed the final portion of data with Health Canada under the rolling submission of its plant-derived COVID-19 vaccine, which was developed using GlaxoSmithKline’s pandemic adjuvant...read more